Drugs / Psiguavin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06512818 | Jan 2025 → Dec 2026 expected | obesity disorder | Universidad Católica San Antonio de Murcia | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Psiguavin | “A purified guava extract will be used, enriched in psiguavin” NCT06512818 ↗ |
| Action | Inhibit | “potential inhibitor of pancreatic lipase” NCT06512818 ↗ |